In vitro diagnostics specialists today have to design systems capable of carrying out increasingly complex tests while making the results easier to interpret. HORIBA Medical has risen to the challenge by considerably intensifying its research efforts. The company aims to invest over 10% of its sales in R&D in the medium term.
Many new concepts, that are unique, have been introduced in the field of in vitro diagnostics, including the most compact system on the market (Micros designed by HORIBA Medical).
Over 40 “key” patent families have been lodged worldwide, covering all the technologies included in our testing systems.

Key indicators

  • Over 1,100 employees
  • 5 production centers (Japan, China, France, Brazil, India)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 14 local/direct operations
  • Around 30,000 laboratories supplied worldwide
HORIBA Medical’s fully-automated haemostasis instrument, the Yumizen G800

17 Sep 2019 - Core lab and near patient instrumentation for haematology and infectious diseases on Stand 615

Read more

Yumizen® H2500 automated haematology analyser

9 Sep 2019 - Studies confirm strong analytical performance for body fluid and pathological sample analysis of...

Read more

27 May 2019 - HORIBA Medical and LABORATORIO ECHEVARNE, one of the major Laboratory Medicine providers in Europe...

Read more